Sonnet BioTherapeutics Holdings, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Sonnet BioTherapeutics Holdings, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Sonnet BioTherapeutics Holdings, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 650K shares, a 197% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 650K +431K +197% Sep 30, 2024 10-K 2024-12-17
Q2 2024 5.22M -33.2M -86.4% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 3.11M -17.4M -84.8% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 3.07M -4.89M -61.5% Dec 31, 2023 10-Q 2024-02-14
Q3 2023 219K -33.2K -13.2% Sep 30, 2023 10-K 2024-12-17
Q2 2023 38.4M -22.2M -36.6% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 20.5M -39.8M -66% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 7.96M -52.3M -86.8% Dec 31, 2022 10-Q 2023-02-13
Q3 2022 252K -4.05M -94.1% Sep 30, 2022 10-K 2023-12-14
Q2 2022 60.6M +35.8M +145% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 60.3M +39.1M +184% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 60.3M +43.1M +251% Dec 31, 2021 10-Q 2022-02-08
Q3 2021 4.3M -10.4M -70.8% Sep 30, 2021 10-K 2022-12-15
Q2 2021 24.8M +15.6M +169% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 21.2M +20.6M +3759% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 17.2M +16.8M +4192% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 14.7M +9.18M +165% Sep 30, 2020 10-K 2021-12-17
Q2 2020 9.2M +2.19M +31.2% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 549K -3.18M -85.3% Mar 31, 2020 10-Q 2020-05-18
Q4 2019 400K -3.32M -89.2% Dec 31, 2019 10-Q 2020-05-18
Q3 2019 5.55M +1.84M +49.7% Sep 30, 2019 10-K 2020-12-17
Q2 2019 7.01M +3.31M +89.6% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 3.73M +510K +15.8% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 3.72M +670K +22% Dec 31, 2018 10-K 2020-03-19
Q3 2018 3.71M +1.19M +47.4% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 3.7M +1.2M +47.9% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 3.22M -18.9M -85.5% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 3.05M +906K +42.4% Dec 31, 2017 10-K 2019-04-01
Q3 2017 2.51M -19.4M -88.6% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 2.5M -19.5M -88.6% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 22.1M +812K +3.81% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 2.14M -19.2M -90% Dec 31, 2016 10-K 2018-03-30
Q3 2016 22M +628K +2.95% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 22M +8.28M +60.5% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 21.3M +9.03M +73.4% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 21.3M +14.1M +194% Dec 31, 2015 10-K 2017-03-31
Q3 2015 21.3M +14.4M +206% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 13.7M +7.18M +111% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 12.3M +5.98M +94.7% Mar 31, 2015 10-Q 2015-05-20
Q4 2014 7.25M +1.86M +34.6% Dec 31, 2014 10-K 2016-03-31
Q3 2014 6.98M +2.51M +56.2% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 6.5M +2.8M +75.5% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 6.32M +2.62M +70.9% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 5.39M +1.69M +45.7% Dec 31, 2013 10-K 2015-04-15
Q3 2013 4.47M +769K +20.8% Sep 30, 2013 10-Q 2013-11-15
Q2 2013 3.7M +4K +0.11% Jun 30, 2013 10-Q 2013-08-12
Q1 2013 3.7M +1.2M +48% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 3.7M +2.45M +196% Dec 31, 2012 10-K 2014-03-31
Q3 2012 3.7M +1.2M +48% Sep 30, 2012 10-Q/A 2012-12-31
Q2 2012 3.7M +1.24M +50.3% Jun 30, 2012 10-Q/A 2013-01-02
Q1 2012 2.5M Mar 31, 2012 10-Q/A 2012-12-28
Q4 2011 1.25M -799K -39% Dec 31, 2011 10-K 2013-04-03
Q3 2011 2.5M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 2.46M Jun 30, 2011 10-Q 2011-08-15
Q4 2010 2.05M Dec 31, 2010 10-K/A 2012-12-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.